CCTN/CHFS Research Competition

The CCTN/CHFS Research Competition was created in 2017 to recognize individuals for outstanding research in the field of heart failure, transplantation, or mechanical circulatory support (MCS). Applicants submitting their research abstract to the Canadian Cardiovascular Congress (CCC) will be given the opportunity to submit their abstract into the CCTN/CHFS Research Competition.

Eligibility Criteria

  1. Only the first author of the abstract will be eligible to submit to the Research Competition. 
  2. To be eligible, the first author must be a non-faculty member at any academic institution/medical center. Examples of eligible applicants include (but are not limited to) students, medical residents or fellows, research fellows including post-doctorate, and allied health care professionals. 
  3. Adult and pediatric, medical and surgical, clinical and basic science research is accepted.

Finalist Presentations

  1. Abstracts that are accepted for presentation at CCC that are submitted to the CCTN-CHFS competition will be considered, and four finalists will be selected for presentation, 2 from the field of heart failure and 2 from transplant/MCS. 
  2. In addition to their CCC abstract poster presentation, each finalist will present a moderated presentation of their research at a CCTN-CHFS Research Competition session at the CCC.

Competition Winners and Awards

  1. A panel of judges will score the presentations, and select a 1st and 2nd prize winner. Winners will be selected based upon the overall quality of the research project, presentation and ability to answer questions in the discussion period. Winners will be announced at the CHFS Annual General Meeting at CCC. 
  2. A prize of $1,000 will be awarded to the 1st place winner and $500 to the 2nd place runner-up, and $250 for 3rd and 4th place finalists. 

A call will go out annually to all CCTN and CHFS members adhering to the CCC Call for Science deadline for Abstract submissions.

 

CCTN/CHFS Research Competition Finalists

2018        

Keith Dadson (Toronto, ON)
“Statins Mediate Recovery from Chemotherapy-Induced Cardiotoxicity”

Natasha Aleksova (Toronto, ON)
“Antiplatelet Therapy and Platelet Reactivity After Heart Transplantation”

Roberto Vanin Pinto Ribeiro (Toronto, ON)
“Is Cold Storage Possible in Hearts Donated After Circulatory Death? A Pre-Clinical Study”

Nariman Sepehrvand (Edmonton, AB)
"High Versus Low Spo2 Oxygen Therapy in Patients with Acute Heart Failure: Hilo-HF Pilot Trial"

2017        

Lior Bibas (Montreal, QC)
“Sarcopenia and Mortality After Heart Transplantation”

Sean Kang (Calgary, AB)
"Direct Effects of Empagliflozin on Extracellular Matrix Remodeling in Human Cardiac Fibroblasts: Novel Translational Clues to Empa-Reg Outcome"

Georges Makhoul (Montreal, QC)
"Human Amniotic Stromal Cells Encapsulated in a Chitosan/Hyaluronic Acid Based Platform Proliferate and Increase Cardiac Function in a Rat Myocardial Infarction Model"

Steve Wright (Ajax, ON)
"Invasive Exercise Hemodynamics of Patients Supported by a Long-Term Continuous-Flow Left Ventricular Assist Device"

 

The CCTN and CHFS would like to thank Servier Canada Inc. for their support of this award.

Servier